A rapid immunoassay for the simultaneous direct detection and differential diagnosis of SARS-CoV-2, Influenza Type A and Type B antigen from nasopharyngeal swab specimens. Flocked nasopharyngeal swab for superior specimen collection and patient comfort.

Sensitivity and Specificity

• SARS-CoV-2 - Sensitivity 93.9%, Specificity 100%
• Flu A - Sensitivity 91.4%, Specificity 95.7%
• Flu B - Sensitivity 87.6%, Specificity 95.9%

Features and benefits:

• Fast results:
  Visual read-out in 15 minutes, and no equipment needed!
• FDA EUA
  Approved under FDA Emergency Use Authorization (EUA)
• Swab included:
  Kit includes extraction buffer vials and flocked nasopharyngeal swabs for superior specimen collection and patient comfort.

Click here for more information